Respiratory Syncytial Virus (RSV) Vaccine

Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms.

$2,600

Plan Details
Items

Vaccine

Respiratory Syncytial Virus (RSV) Vaccine

Manufacturer

GSK

Doses in Routine Series

1 Dose

Working Hours

Monday to Friday:9 am – 6 pm
Saturday:9 am – 1 pm
Sunday and Public Holiday:Closed

eHealth System & Health Care Voucher

We can upload images to eHRSS.
We support the use of Health Care Voucher.

More Information
RSV Vaccine
Details

RSV is a common virus that can cause serious respiratory illness, especially in infants and older adults.

The RSV vaccine has been shown to have a protective efficacy of approximately 82.6% to 94.6%. This is an impressively high level of protection, which would create a strong immune barrier, especially for high-risk populations like infants and the elderly.

Who Should Get RSV Vaccination?
Details

Recommendations for individuals aged 60 and above, especially those with chronic illnesses, to receive early vaccination.

 

Incubation period
Details

The incubation period is 1 – 10 days, usually 5 – 7 days.